Keay Nakae
Stock Analyst at Chardan Capital
(3.42)
# 857
Out of 4,944 analysts
247
Total ratings
32.5%
Success rate
8.54%
Average return
Main Sectors:
Stocks Rated by Keay Nakae
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OBIO Orchestra BioMed Holdings | Maintains: Buy | $20 | $2.65 | +654.72% | 12 | Aug 13, 2025 | |
| KRRO Korro Bio | Maintains: Buy | $25 | $20.00 | +25.00% | 3 | Aug 13, 2025 | |
| MNPR Monopar Therapeutics | Maintains: Buy | $60 | $36.36 | +65.02% | 2 | Aug 13, 2025 | |
| COYA Coya Therapeutics | Maintains: Buy | $14 | $5.70 | +145.83% | 20 | Aug 13, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $60 | $18.78 | +219.49% | 20 | Aug 11, 2025 | |
| ABUS Arbutus Biopharma | Maintains: Buy | $5 | $3.37 | +48.37% | 13 | Aug 11, 2025 | |
| PRQR ProQR Therapeutics | Maintains: Buy | $4 | $2.03 | +97.53% | 15 | Aug 8, 2025 | |
| RNA Avidity Biosciences | Maintains: Buy | $75 | $46.07 | +62.80% | 18 | Aug 8, 2025 | |
| SABS SAB Biotherapeutics | Maintains: Buy | $20 → $12 | $2.20 | +445.45% | 16 | Aug 8, 2025 | |
| SLN Silence Therapeutics | Maintains: Buy | $35 | $5.60 | +525.00% | 13 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $400 | $442.73 | -9.65% | 14 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $38 | $12.51 | +203.76% | 13 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 | $0.68 | +637.25% | 5 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $1.25 → $6 | $16.85 | -64.39% | 10 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 | $3.76 | +431.91% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 | $1.54 | +289.61% | 7 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $2.5 | $2.48 | +0.81% | 6 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $0.72 | +1,005.58% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.45 | - | 5 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $8 → $6 | $15.86 | -62.17% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $20 | $0.51 | +3,836.23% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $55 | $8.82 | +523.58% | 10 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.25 → $10 | $6.87 | +45.67% | 5 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $100 → $88 | $10.78 | +711.69% | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $0.7 → $13 | $1.03 | +1,162.14% | 3 | Feb 9, 2021 |
Orchestra BioMed Holdings
Aug 13, 2025
Maintains: Buy
Price Target: $20
Current: $2.65
Upside: +654.72%
Korro Bio
Aug 13, 2025
Maintains: Buy
Price Target: $25
Current: $20.00
Upside: +25.00%
Monopar Therapeutics
Aug 13, 2025
Maintains: Buy
Price Target: $60
Current: $36.36
Upside: +65.02%
Coya Therapeutics
Aug 13, 2025
Maintains: Buy
Price Target: $14
Current: $5.70
Upside: +145.83%
Arrowhead Pharmaceuticals
Aug 11, 2025
Maintains: Buy
Price Target: $60
Current: $18.78
Upside: +219.49%
Arbutus Biopharma
Aug 11, 2025
Maintains: Buy
Price Target: $5
Current: $3.37
Upside: +48.37%
ProQR Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $4
Current: $2.03
Upside: +97.53%
Avidity Biosciences
Aug 8, 2025
Maintains: Buy
Price Target: $75
Current: $46.07
Upside: +62.80%
SAB Biotherapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $20 → $12
Current: $2.20
Upside: +445.45%
Silence Therapeutics
Aug 8, 2025
Maintains: Buy
Price Target: $35
Current: $5.60
Upside: +525.00%
Aug 1, 2025
Maintains: Buy
Price Target: $325 → $400
Current: $442.73
Upside: -9.65%
Jul 29, 2025
Maintains: Buy
Price Target: $50 → $38
Current: $12.51
Upside: +203.76%
Jun 25, 2025
Maintains: Buy
Price Target: $5
Current: $0.68
Upside: +637.25%
May 8, 2025
Downgrades: Neutral
Price Target: $1.25 → $6
Current: $16.85
Upside: -64.39%
Apr 7, 2025
Maintains: Buy
Price Target: $20
Current: $3.76
Upside: +431.91%
Mar 28, 2025
Maintains: Buy
Price Target: $6
Current: $1.54
Upside: +289.61%
Mar 27, 2025
Maintains: Neutral
Price Target: $2.5
Current: $2.48
Upside: +0.81%
Nov 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $0.72
Upside: +1,005.58%
Feb 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.45
Upside: -
Aug 4, 2023
Maintains: Sell
Price Target: $8 → $6
Current: $15.86
Upside: -62.17%
Nov 10, 2022
Maintains: Buy
Price Target: $60 → $20
Current: $0.51
Upside: +3,836.23%
Nov 9, 2022
Maintains: Buy
Price Target: $65 → $55
Current: $8.82
Upside: +523.58%
Aug 16, 2022
Maintains: Neutral
Price Target: $1.25 → $10
Current: $6.87
Upside: +45.67%
Sep 20, 2021
Upgrades: Neutral
Price Target: $100 → $88
Current: $10.78
Upside: +711.69%
Feb 9, 2021
Downgrades: Neutral
Price Target: $0.7 → $13
Current: $1.03
Upside: +1,162.14%